Inquiry on the effectiveness of marijuana in treating rheumatoid arthritis.
In the realm of rheumatoid arthritis (RA) treatment, a potential new contender is emerging: medical cannabis. Recent research indicates that this substance, particularly cannabidiol (CBD), shows promising effectiveness in reducing pain and inflammation associated with RA.
Biologic DMARDs, such as abatacept (Orencia) and golimumab (Simponi), specifically target immune cells and modify the inflammatory response. However, medical cannabis might offer a more targeted approach. High-CBD cannabis extracts have been shown to inhibit proliferation of synovial fibroblasts implicated in joint damage, suppress secretion of pro-inflammatory cytokines by immune cells, and reduce production of enzymes like inducible nitric oxide synthase (iNOS) that contribute to cartilage damage. These mechanisms suggest CBD targets underlying inflammatory pathways in RA, beyond symptomatic pain relief.
Clinical evidence supports these findings. Studies published in the Journal of Cannabis Research found CBD reduced both pain and inflammation in RA patients, pointing towards its therapeutic potential. Medical cannabis is also considered a valuable option for chronic pain management in arthritis patients, potentially helping reduce reliance on opioids and other pharmaceuticals that carry higher risk profiles.
While these findings are encouraging, larger, long-term clinical trials are needed to fully establish optimal dosages, formulations, and safety profiles in RA. Current evidence supports medical cannabis as a promising adjunct for symptom management rather than a replacement for conventional disease-modifying treatments.
Besides RA, medical cannabis may be prescribed for conditions such as chronic pain, cancer, Parkinson's disease, and other conditions that affect an individual's quality of life. The primary benefit of medical cannabis for people living with RA is that it can ease chronic pain. However, potential risks include mental health symptoms such as suicidal thoughts and increased risk of depression, as well as the potential for substance dependence.
In conclusion, medical cannabis, particularly CBD, is emerging as an effective and safer complementary treatment for managing rheumatoid arthritis symptoms by reducing inflammation and pain. As research continues to clarify its role in clinical practice, anyone living with RA and considering the use of medical cannabis should discuss the potential benefits and risks with a doctor to determine its suitability.
[1] Iuvone, T., Esposito, G., Esposito, R., & Izzo, A. A. (2018). Cannabidiol as potential anticancer agent: A comprehensive review. Molecules (Basel, Switzerland), 23(10), 2478.
[2] Russo, E. B. (2016). Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management, 12, 183-194.
[3] Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(3), 336-352.
[4] Whiting, P. F., Wolff, R. S., Deshpande, S., Di Nisio, M., Duffy, S., & Hampson, A. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456-2473.
[5] Russo, E. B. (2008). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 153(3), 199-215.
- CBD, a component in medical cannabis, has shown potential in reducing inflammation and pain associated with rheumatoid arthritis (RA), targeting underlying inflammatory pathways.
- The Journal of Cannabis Research published studies indicating that CBD can reduce both pain and inflammation in RA patients, showing its therapeutic potential for chronic diseases and medical-conditions.
- Given its effectiveness in manageing chronic pain and potential for reducing reliance on opioids, medical cannabis is considered a valuable option for therapies-and-treatments in the health-and-wellness industry, particularly for those living with chronic diseases like RA.
- However, it's important to note that while CBD holds promise, larger, long-term clinical trials are necessary to establish optimal dosages, formulations, and safety profiles in RA, making it more suited as an adjunct for symptom management rather than a replacement for conventional treatments.
- Beyond RA, medical cannabis may be prescribed for conditions such as chronic pain, cancer, Parkinson's disease, and other medical-conditions that affect an individual's quality of life, offering relief for symptoms like chronic pain.
